HomeDERMALOG Identification Systems GmbHThe DERMALOG "Iris Matching" Scores with Accuracy and Convenience

The DERMALOG “Iris Matching” Scores with Accuracy and Convenience


The biometric Iris Solution by DERMALOG provides the speed of more than 8.5 million Matches per second, certified by the SGS-TUV Saar

The biometric Iris Solution by DERMALOG provides the speed of more than 8.5 million Matches per second, certified by the SGS-TUV Saar. In working with digital iris images the Iris Recognition shows a precision that is made for using with large-scale data sets. Collected iris images and worked out details (templates) serve for registration, verification and identification.

The leading German multi-biometrics provider and system integrator DERMALOG has applied for certifying the quality of his “Iris Matching”. The certification of SGS-TUV Saar indicates for the speed: the Iris Matching achieves more than 8.5 million “Matches” per second on a single blade including 40 CPU-cores.

Gunther Mull, DERMALOG managing director reports: “Identification and verification of individuals by means of iris characteristics demonstrates a high accuracy. In addition, this biometric technology is contactless, therefore very hygienic and requires very little maintenance. Especially large installations like national ID databases, customs authorities and Border Control facilities benefit from fast and reliable solutions.”

The company notes the DERMALOG solution supports a series of infrared iris cameras. Amongst other things infrared lighting provides that in recordings of eyes of dark colour – sufficient details are visible. Additionally the photography can be taken without extensive preparation time and from a longer distance. Gunther Mull: “The DERMALOG Iris Recognition software is able to process recordings of poor quality. The Iris Recognition is a future-proof technology for biometric data matching – an innovation Made in Germany.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy